Recommendations Major Recommendations
The levels of recommendation (1-3) and classification of evidence (I-III) are defined at the end of the "Major Recommendations" field.
Note: Some recommendations from the 2001 Eastern Association for the Surgery of Trauma (EAST) mild traumatic brain injury (MTBI) guidelines are essentially unchanged in this update. However, a number of alterations and additions have been made. The previous admonition to obtain a brain computed tomographic (CT) scan in all patients with suspected brain injury has been modified to reflect the use of standardized criteria (such as the Canadian CT Head Rule [CCHR] ) in some centers to identify patients that require a CT scan. The indications for emergency department (ED) discharge of patients with MTBI were examined in a number of high-volume studies since 2001, and our recommendation was changed to Level II to reflect this. Two specific recommendations on anticoagulated patients with MTBI were added.
Level 1
There are no level 1 recommendations.
Level 2 1. Clinicians should perform brain CT scan on patients that present with suspected brain injury in the acute setting if it is available. 2. If CT resources are limited, consideration may be given to the use of a set of standardized criteria (e.g., the Canadian CT Head Rule
[CCHR], New Orleans Criteria [NOC]) to determine which patients with MTBI receive a brain CT scan. Clinicians should be aware that this practice is associated with a nonzero missed injury rate. Mild traumatic brain injury is defined as an acute alteration in brain function caused by a blunt external force and is characterized by a Glasgow Coma Scale (GCS) score of 13 to 15, loss of consciousness for 30 minutes or less, and duration of posttraumatic amnesia of 24 hours or less. The terms mild traumatic brain injury and concussion may be used interchangeably. A comprehensive review of the management of concussion in athletes is beyond the scope of this practice management guideline (PMG Additional references were obtained in the reference sections of retrieved articles, from review articles, and from Web resources. English-language references from 1980 to 2011 were examined, and articles published after 1999 were emphasized. A significant number of studies that were noncontributory were excluded. There was a notable lack of randomized, controlled trials, and it was not possible to restrict our review of any mild traumatic brain injury (MTBI) subtopic to such trials.
Number of Source Documents
A total of 112 articles were reviewed.
Methods Used to Assess the Quality and Strength of the Evidence
Weighting According to a Rating Scheme (Scheme Given)
Rating Scheme for the Strength of the Evidence Class I: Prospective randomized clinical trials.
Class II: Clinical studies in which data were collected prospectively or retrospective analyses based on clearly reliable data.
Class III: Studies based on retrospectively collected data. Rating Scheme for the Strength of the Recommendations
Methods Used to Analyze the Evidence
Level 1: The recommendation is convincingly justifiable based on the available scientific information alone. This recommendation is usually based on Class I data, however, strong Class II evidence may form the basis for a Level I recommendation, especially if the issue does not lend itself to testing in a randomized format. Conversely, low quality or contradictory Class I data may not be able to support a Level I recommendation.
Level 2: The recommendation is reasonably justifiable by available scientific evidence and strongly supported by expert opinion. This recommendation is usually supported by Class II data or a preponderance of Class III evidence.
Level 3: The recommendation is supported by available data but adequate scientific evidence is lacking. This recommendation is generally supported by Class III data. This type of recommendation is useful for educational purposes and in guiding future clinical research.
Cost Analysis
A formal cost analysis was not performed and published cost analyses were not reviewed.
Method of Guideline Validation
Internal Peer Review
Description of Method of Guideline Validation
All authors participated in critical revision and approved the final version.
Evidence Supporting the Recommendations Type of Evidence Supporting the Recommendations
The type of supporting evidence is identified and graded for each recommendation (see the "Major Recommendations" field).
Benefits/Harms of Implementing the Guideline Recommendations
Potential Benefits
Potential Benefits
Appropriate evaluation and management of patients with mild traumatic brain injury (MTBI)
Potential Harms
The practice of obtaining a brain computed tomography (CT) scan for every patient that could conceivably have positive findings leads to a significant number of negative study findings and may also be burdensome from a financial and resource standpoint. Efforts to achieve an overall reduction on CT use will inevitably lead to a higher missed injury rate, although whether these injuries are clinically significant is debatable.
Contraindications Contraindications
Patients with a minor traumatic brain injury who are therapeutically anticoagulated (e.g., with warfarin, clopidogrel, or other agents) may warrant special consideration. Trauma patients in general have a significant incidence of individual symptoms that overlap with postconcussive syndrome (PCS), especially those with posttraumatic stress disorder. It has been noted that the high incidence of posttraumatic stress disorder in combat veterans is a significant confounding factor in terms of determining if reported symptoms are truly caused by the blunt head injury itself.
Qualifying Statements Qualifying Statements
The natural history of mild traumatic brain injury (MTBI) is poorly understood in part because the studies conducted thus far vary widely in their inclusion criteria, methodology, and outcome variables measured. The studies tend to be scattered across a wide variety of journals in a number of disciplines and originate in many different countries. As a result, there has been an accumulation of a large number of studies in which each uses a different measurement tool to describe a set of different outcome variables in its own unique study population. The epidemiology of MTBI remains poorly understood in part owing to inconsistent definitions and terminology. These factors make it difficult to determine exactly what percentage of all patients with traumatic brain injury (TBI) have an MTBI. The Eastern Association for the Surgery of Trauma (EAST) is a multi-disciplinary professional society committed to improving the care of injured patients. The Ad hoc Committee for Practice Management Guideline Development of EAST develops and disseminates evidencebased information to increase the scientific knowledge needed to enhance patient and clinical decision-making, improve health care quality, and promote efficiency in the organization of public and private systems of health care delivery. Unless specifically stated otherwise, the opinions expressed and statements made in this publication reflect the authors' personal observations and do not imply endorsement by nor official policy of the Eastern Association for the Surgery of Trauma. "Clinical practice guidelines are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances."* These guidelines are not fixed protocols that must be followed, but are intended for health care professionals and providers to consider. While they identify and describe generally recommended courses of intervention, they are not presented as a substitute for the advice of a physician or other knowledgeable health care professional or provider. Individual patients may require different treatments from those specified in a given guideline. Guidelines are not entirely inclusive or exclusive of all methods of reasonable care that can obtain/produce the same results. While guidelines can be written that take into account variations in clinical settings, resources, or common patient characteristics, they cannot address the unique needs of each patient nor the combination of resources available to a particular community or health care professional or provider. Deviations from clinical practice guidelines may be justified by individual circumstances. Thus, guidelines must be applied based on individual patient needs using professional judgment.
